Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The characteristics and clinical relevance of tumor fusion burden in non-EBV (+) gastric cancer with MSS.

BMC gastroenterology - 15 May 2023

Zhu Yongjun, Wu Weixin, Qiao Liangliang, Ji Jingfen, Duan Lunxi, Gong Longlong, Ren Dandan, Li Feifei, Wei Lihui, Pan Ke

Abstract excerpt

BACKGROUND: Next-generation sequencing (NGS) is maturely applied for gene fusion detection. Although tumor fusion burden (TFB) has been identified as an immune marker for cancer, the relationship between these fusions and the immunogenicity and molecular characteristics of gastric cancer (GC) patients remains unclear. GCs have different clinical significance depending on their subtypes, and thus, this study aimed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Clinical Relevance

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Epstein-Barr Virus Infections

Share to Mutation

Share to Prognosis

Share to Stomach Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 37189078
DOI: 10.1186/s12876-023-02765-9
PMCID: PMC10184333

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The characteristics and clinical relevance of tumor fusion burden in non-EBV (+) gastric cancer with MSS.PMID 37189078Read ↗

Emerging molecular classifications and therapeutic implications for gastric cancer.Semantic proximity Read ↗

Classification of gastric cancer by EBV status combined with molecular profiling predicts patient prognosisSemantic proximity Read ↗

Differences in the Tumor Microenvironment of EBV-Associated Gastric Cancers Revealed Using Single-Cell Transcriptome AnalysisSemantic proximity Read ↗

Tumor Mutation Burden: A Predictive Biomarker for Gastric Cancer ImmunotherapySemantic proximity Read ↗

Characterization of Tumor Mutation Burden-Based Gene Signature and Molecular Subtypes to Assist Precision Treatment in Gastric Cancer.Semantic proximity Read ↗

Clinicopathological Features of Epstein-Barr Virus Infection, Microsatellite Instability, Tumor Mutation Burden and PD-L1 Status in Chinese Patients with Gastric CancerSemantic proximity Read ↗

Identification of a Gene Prognostic Model of Gastric Cancer Based on Analysis of Tumor Mutation Burden.Semantic proximity Read ↗

Somatic mutations that affect early genetic progression and immune microenvironment in gastric carcinoma.Semantic proximity Read ↗

Overview of Epstein–Barr-Virus-Associated Gastric Cancer Correlated with Prognostic Classification and Development of Therapeutic OptionsSemantic proximity Read ↗

TM-Score predicts immunotherapy efficacy and improves the performance of the machine learning prognostic model in gastric cancer.Semantic proximity Read ↗

Identifying molecular drivers of gastric cancer through next-generation sequencing.Semantic proximity Read ↗

Significance of Tumor Mutation Burden Combined With Immune Infiltrates in the Progression and Prognosis of Advanced Gastric CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.